ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1) | Zendy

М. Г. Бубнова | Zendy

Open Access

ARB I olmesartan interruption in cardiovascular and cardiorenal continuum: antihypertensive and nephroprotective effects (part 1)

Author(s) -

М. Г. Бубнова

Publication year - 2014

Publication title -

cardiosomatics

Language(s) - English

Resource type - Journals

eISSN - 2658-5707

pISSN - 2221-7185

DOI - 10.26442/cs45121

Subject(s) - olmesartan , tolerability , medicine , pharmacology , antihypertensive drug , angiotensin receptor , drug , cardiology , angiotensin ii , blood pressure , adverse effect

The article provides an overview of the efficacy and tolerability of one of the representatives of the class angiotensin receptor blockers II - olmesartan medoxomil (Kardosal). Analyzed are the characteristics and pharmacological activity of olmesartan medoxomil antihypertensive monotherapy, in combination with other antihypertensive drugs, in different groups of patients. The article describes the renal protective properties of the drug, its safety profile. It also discusses the reasons for poor adherence therapy in patients with arterial hypertension.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research